ValGenesis, Inc. today announced that an elite biotechnology company selected ValGenesis VLMS for digitizing multiple validation processes across the organization.
Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 study ( NCT05658107 ) to assess the safety, tolerability, and pharmacokinetics in healthy volunteers.
On April 16th 2023, the first International Conference on Single-cell and Spatial Omics (TICSSO-1) has come to a grand conclusion.
Dos estrellas masivas orbitan tan cerca una de la otra que sus partes externas se tocan. Se prevé que su historia futura sea aún más llamativa, con la estrella que ahora pierde más materia convirtiéndose en un agujero negro y recuperándola con creces de la e …
El robot chino Zhurong, que circula sobre la superficie de Marte desde 2021, ha encontrado indicios de agua líquida reciente en superficies de dunas marcianas. Así lo ha verificado en un estudio el equipo de Xiaoguang Qin del Instituto de Geología y Geofísica (IG …
En este Short presentamos un sistema basado en bacterias que es capaz de producir electricidad a muy largo plazo. …
Dispositivo que suministra electricidad durante un siglo Read More »
AdaptHealth Corp. announced today that Stephen Griggs will step down as Chief Executive Officer by mutual agreement with the Board of Directors, effective June 30, 2023.
AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter Read More »
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that the first United States-based patient has been enrolled in the Phase III HARMONi study.
Perrigo Company plc (NYSE: PRGO) (“Perrigo” or the “Company”), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter ended April 1, 2023.
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products , today announced that Murray S. Kessler has notified the Company of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.
Perrigo Announces Chief Executive Officer Retirement and Succession Plan Read More »
